Does YTTRIUM Y-90 Cause Malignant neoplasm progression? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Malignant neoplasm progression have been filed in association with YTTRIUM Y-90. This represents 6.0% of all adverse event reports for YTTRIUM Y-90.
8
Reports of Malignant neoplasm progression with YTTRIUM Y-90
6.0%
of all YTTRIUM Y-90 reports
7
Deaths
0
Hospitalizations
How Dangerous Is Malignant neoplasm progression From YTTRIUM Y-90?
Of the 8 reports, 7 (87.5%) resulted in death.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for YTTRIUM Y-90. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does YTTRIUM Y-90 Cause?
Abdominal pain (17)
Off label use (15)
Disease progression (14)
Drug ineffective (14)
Metastases to liver (12)
Pyrexia (12)
Fatigue (11)
Thrombocytopenia (11)
Pancreatic carcinoma metastatic (10)
Pancreatic neuroendocrine tumour metastatic (9)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which YTTRIUM Y-90 Alternatives Have Lower Malignant neoplasm progression Risk?
YTTRIUM Y-90 vs ZAFIRLUKAST
YTTRIUM Y-90 vs ZALCITABINE
YTTRIUM Y-90 vs ZALEPLON
YTTRIUM Y-90 vs ZANAMIVIR
YTTRIUM Y-90 vs ZANIDATAMAB